Results 241 to 250 of about 5,740,750 (360)

Shared Decision Making: The Prerequisite for Substantial Autonomy in Evidence-Based Practice. [PDF]

J Eval Clin Pract
Bacchi AD.
europepmc   +1 more source

Genetic attenuation of ALDH1A1 increases metastatic potential and aggressiveness in colorectal cancer

Molecular Oncology, EarlyView.
Aldehyde dehydrogenase 1A1 (ALDH1A1) is a cancer stem cell marker in several malignancies. We established a novel epithelial cell line from rectal adenocarcinoma with unique overexpression of this enzyme. Genetic attenuation of ALDH1A1 led to increased invasive capacity and metastatic potential, the inhibition of proliferation activity, and ultimately ...
Martina Poturnajova, Zuzana Kozovska, Ondrej Pos, Kristina Pavlov, Sachin Gulati, Peter Makovicky, Kristina Jakic, Monika Burikova, Eva Sedlackova, Barbora Svitkova, Silvia Tyciakova, Vojtech Bystry, Nicolas Blavet, Boris Tichy, Matej Hrnciar, Jaroslav Budis, Miroslav Tomas, Peter Dubovan, Georgina Kolnikova, Veronika Repaska, Nikoleta Mojzesova, Eva Zomborska, Daniel Pindak, Michal Mego, Tomas Szemes, Miroslava Matuskova   +25 more
wiley   +1 more source

<i>Scientia Potentia Est</i>: Engagement in Research Strengthens Evidence-Based Practice and Patient Care. [PDF]

Hosp Pharm
Belančić A, Mikolašević I.
europepmc   +1 more source

Beta Blockers Use in Cardiac Failure: Does the Current Prescribing Practice at a Large Urban Hospital in Zimbabwe Exhibit Evidence Based Care and Offer Optimal Therapy for Cardiac Failure Patients?

, 2015
Patrick Rutendo Matowa
openalex   +2 more sources

Targeted modulation of IGFL2‐AS1 reveals its translational potential in cervical adenocarcinoma

Molecular Oncology, EarlyView.
Cervical adenocarcinoma patients face worse outcomes than squamous cell carcinoma counterparts despite similar treatment. The identification of IGFL2‐AS1's differential expression provides a molecular basis for distinguishing these histotypes, paving the way for personalized therapies and improved survival in vulnerable populations globally.
Ricardo Cesar Cintra, Lucca Paolo Hsu Helmich, Daniel Rodrigues de Bastos, Laura Sichero, Patrícia Savio de Araujo‐Souza, Fabio Passetti, Luisa Lina Villa   +6 more
wiley   +1 more source

Nurse-Led Evidence-Based Practice to Promote Gastrointestinal Function Recovery in Women After Cesarean Delivery. [PDF]

Int J Womens Health
Lin L, Chen P, Wan T, Xie G, Wang P, Yan X, Li R, Chen W, Zhang W.   +8 more
europepmc   +1 more source

Evidence based practice in counselling and psychotherapy

, 2001
Alan Carr
openalex   +1 more source

CHDmap: One Step Further Toward Integrating Medicine-Based Evidence Into Practice [PDF]

Jef Van den Eynde
openalex   +1 more source

Indoleamine 2,3‐dioxygenase 1 inhibition reverses cancer‐associated fibroblast‐mediated immunosuppression in high‐grade serous ovarian cancer

FEBS Open Bio, EarlyView.
CAF‐mediated immunosuppression in ovarian cancer is driven by IDO1, reducing T‐cell function. Inhibiting IDO1 restores T‐cell proliferation and cytotoxicity, increases cancer cell apoptosis, and may help overcome CAF‐induced immune suppression in high‐grade serous ovarian cancer. Targeting IDO1 may improve antitumor immunity.
Hyewon Lee, Jung Yoon Ho, In Sun Hwang, Youn Jin Choi   +3 more
wiley   +1 more source

The Impact of the Evidence-Based Practice Mentor on Nurses: A Scoping Review. [PDF]

Worldviews Evid Based Nurs
Agnel J, Molle J, Colson S, Chays-Amania A.   +3 more
europepmc   +1 more source